Skip to content

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Community Screening Study of Diabetic Retinopathy in Tianjin in 2024

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06478407
Acronym
CSSODRIT
Enrollment
18000
Registered
2024-06-27
Start date
2024-03-28
Completion date
2025-03-28
Last updated
2024-07-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetic Retinopathy

Keywords

diabetic retinopathy

Brief summary

Through this study, the investigators hope to understand the prevalence and influencing factors of diabetic retinopathy in Tianjin, improve the ability of complication detection and intervention in diabetic patients in primary medical and health institutions, and build a diabetes prevention and treatment network. The investigators should adhere to the policy of prevention first, combined with prevention and control, and explore a diabetes' prevention and control model suitable for our city. Extensive publicity and education should be carried out to improve the awareness of self-management ,improve the screening rate of diabetic retinopathy, and reduce the blindness rate.

Detailed description

West of the city, and hebei, heping and binhai new area to carry out the work, diabetic retinopathy screening on 18000 diabetic patients in fundus examination. Tianjin medical university eye hospital, project team, formed in grassroots medical institutions are responsible for screening fundus examination in patients with diabetes, related inspection including vision, computer optometry, fundus photography and optical coherence tomography angiography (OCTA), etc. Blood samples were collected from patients in Hexi District and Heping District to detect glycosylated hemoglobin. Glycated albumin, urine ACR and CO breath test were performed in Chu Hsien-I Memorial Hospital of Tianjin Medical University. Health records were established for the screening personnel after the examination

Interventions

None listed

Sponsors

Tianjin Medical University Eye Hospital
CollaboratorOTHER
Li Xiaorong
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Healthy volunteers
Yes

Inclusion criteria

\- 1: Clear awareness, barrier-free communication 2: diabetes

Exclusion criteria

* 1: Have left the registered home address 2: In the last 6 months, you have not lived in your place of residence 3: Have a serious mental illness

Design outcomes

Primary

MeasureTime frameDescription
Classification of diabetic retinopathyAt screeningFundus images were taken by fundus camera and graded

Secondary

MeasureTime frameDescription
OCTA imaging indicatorsAt screeningOCTA machine was used to photograph the fundus
blood biochemistryAt screeningBlood was collected and tested
glycosylated hemoglobinAt screeningBlood was collected and tested
blood routine examinationAt screeningBlood was collected and tested
Urine ACRAt screeningUrine was collected and tested
Blood vessel color Doppler ultrasound of extremitiesAt screeningBlood vessels of extremities were photographed by color Doppler ultrasound
glycated albuminAt screeningBlood was collected and tested

Countries

China

Contacts

Primary ContactJuping Liu, Director
tydljp@126.com13752033227

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026